person

Florent C.

Country
France
Department
Médecine Nucleaire

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 4 partner sites.

Specializations

Hematologic Oncology

The investigator specializes in innovative therapeutic approaches for acute leukemia, with particular emphasis on treatment-resistant cases. Their research interests encompass the development of targeted therapies using radioligand treatments.

  • Leukemia Management
  • Advanced Therapeutic Modalities
  • Hematologic Malignancies

The investigator focuses on evaluating novel treatment strategies for patients with relapsed or refractory disease conditions.

Nuclear Medicine

The investigator has developed expertise in radioligand therapy applications, particularly focusing on CXCR4-positive malignancies. Their work involves exploring targeted therapeutic approaches using radioisotope-based treatments.

  • Molecular Targeting
  • Radioligand Applications
  • Receptor-Based Therapy

Their research encompasses the implementation of precision medicine approaches in hematologic conditions.

Therapeutic Innovation

The investigator's work centers on developing advanced treatment modalities for challenging hematologic conditions. Their expertise includes the evaluation of novel therapeutic compounds for resistant disease forms.

  • Treatment Resistance
  • Novel Therapeutic Approaches
  • Clinical Applications

Their focus includes investigating emerging treatment options for patients with limited therapeutic alternatives.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.